GPC3 and hepatocellular carcinoma: Lee et al. (2006) identified complement C3a as a candidate biomarker for HCV-related HCC by proteomics. Malov et al. (2021) confirmed that heparin binds to growth factors, glypican-3 and osteopontin could serve as HCV-associated HCC markers.